格菲提尼布诱导子宫癌细胞中的阿诺基斯
Byung Chul Jung1, Sung-Hun Woo2, Sung Hoon Kim3
1Department of Nutritional Sciences and Toxicology, University of California, Berkeley, CA 94720, USA; Department of Biomedical Laboratory Science, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju 26493, Korea.
BMB reports
|February 2, 2024
概括
格菲提尼布通过破坏细胞粘附,在宫癌细胞中触发了细胞亡或编程细胞死亡. 这一发现表明gefitinib是治疗宫癌的潜在新疗法.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 分子医学是分子医学.
背景情况:
- 格菲提尼布是治疗多种癌症的有效抗癌药物.
- 它在宫癌中的疗效和机制尚不清楚.
研究的目的:
- 调查gefitinib在宫癌中的治疗潜力.
- 阐明基菲提尼布对宫癌细胞作用的分子机制.
主要方法:
- 用gefitinib治疗宫癌细胞系 (HeLa和C33A) 的方法.
- 对亡诱导,细胞骨变化和粘附分子表达的分析 (p-FAK,整合素β1,E-cadherin).
- 评估细胞的重新连接,扩散和衰老.
主要成果:
- 格菲提尼布在HeLa和C33A细胞中诱导了酶依赖的亡和亡.
- 盖菲提尼布导致了actin细胞骨的重组,并降低了p-FAK,整体蛋白β1和E-cadherin的调节.
- 该药物抑制了细胞粘附,重新附着和扩散,导致了细胞亡.
结论:
- 格菲提尼布有效触发子宫癌细胞中的阿诺基斯 (脱离诱导的亡).
- 该机制涉及细胞粘附和细胞骨完整性的破坏.
- 这些发现支持gefitinib作为宫癌的潜在治疗剂.
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
163
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
163
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K


